Predictions
Uniqure B.V.
Start price
Target price
Perf. (%)
€5.16
21.01.24
21.01.24
-
21.01.25
21.01.25
-4.65%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.08
21.01.24
21.01.24
-
21.01.25
21.01.25
21.10%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.91
21.01.24
21.01.24
-
21.01.25
21.01.25
7.87%
03.02.24
03.02.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€75.00
21.01.24
21.01.24
-
21.01.25
21.01.25
-2.67%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€3.44
20.01.24
20.01.24
€1.00
20.01.25
20.01.25
3.49%
03.02.24
03.02.24
High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.95
18.01.24
18.01.24
-
18.01.25
18.01.25
-14.44%
21.01.24
21.01.24
Could be worthwhile Investment >10% per year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.98
18.01.24
18.01.24
-
18.01.25
18.01.25
-3.63%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Ascendis Ph.sp.adr 1 Dk 1
Start price
Target price
Perf. (%)
€122.00
17.01.24
17.01.24
-
17.01.25
17.01.25
-2.46%
31.01.24
31.01.24
Seres Therapeutics Inc
Start price
Target price
Perf. (%)
€1.32
09.01.24
09.01.24
-
09.01.25
09.01.25
-6.06%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Grifols S.A.
Start price
Target price
Perf. (%)
€9.54
09.01.24
09.01.24
-
09.01.25
09.01.25
24.03%
10.01.24
10.01.24
Could be worthwhile Investment >10% per year
Good culture
Few uniques
Uniqure B.V.
Start price
Target price
Perf. (%)
€5.79
07.01.24
07.01.24
-
07.01.25
07.01.25
-10.88%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.78
07.01.24
07.01.24
-
07.01.25
07.01.25
9.88%
03.03.24
03.03.24
Could be worthwhile Investment >10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.62
07.01.24
07.01.24
-
07.01.25
07.01.25
-11.80%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.02
07.01.24
07.01.24
-
07.01.25
07.01.25
-16.47%
19.01.24
19.01.24
Probably not worthwhile Investment
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cellectar BioSciences Inc.
Start price
Target price
Perf. (%)
€2.74
03.01.24
03.01.24
-
03.01.25
03.01.25
-3.65%
06.01.24
06.01.24
Risky Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.96
02.01.24
02.01.24
€80.00
02.02.24
02.02.24
-6.29%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Crossject S.A.
Start price
Target price
Perf. (%)
€4.89
30.12.23
30.12.23
€5.50
30.12.24
30.12.24
-22.39%
10.02.24
10.02.24
Could be worthwhile Investment >10% per year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€2.64
28.12.23
28.12.23
-
28.12.24
28.12.24
-9.11%
06.01.24
06.01.24
Risky Investment
Coherus Bioscien.
Start price
Target price
Perf. (%)
€2.60
27.12.23
27.12.23
-
27.12.24
27.12.24
12.33%
21.01.24
21.01.24
Could be very worthwhile Investment >20% year
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€1.83
27.12.23
27.12.23
-
27.12.24
27.12.24
-2.62%
07.01.24
07.01.24
Could be very worthwhile Investment >20% year
Coherus Bioscien.
Start price
Target price
Perf. (%)
€2.60
27.12.23
27.12.23
€3.00
27.12.24
27.12.24
13.68%
28.12.23
28.12.23
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.06
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.96%
11.01.24
11.01.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
AC Immune Ltd
Start price
Target price
Perf. (%)
€4.16
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.05%
19.01.24
19.01.24
Could be worthwhile Investment >10% per year